PIN30 COST-MINIMIZATION ANALYSIS OF ORALVALGANCICLOVIR VERSUS INTRAVENOUS GANCICLOVIR FORTHE PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS IN BRAZIL
May 1, 2008, 00:00
10.1016/S1098-3015(10)70328-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)70328-4/fulltext
Title :
PIN30 COST-MINIMIZATION ANALYSIS OF ORALVALGANCICLOVIR VERSUS INTRAVENOUS GANCICLOVIR FORTHE PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70328-4&doi=10.1016/S1098-3015(10)70328-4
First page :
Section Title :
Open access? :
No
Section Order :
31